Search This Blog

Saturday, April 6, 2019

Investors should not buy into craze for hemp stocks, Barron’s says

Congress legalized hemp and its soothing extract cannabidiol, or CBD, and now the stock market cannot get enough of the stuff, Bill Alpert writes in this week’s edition of Barron’s. Cannabis producers like Canopy Growth (CGC), Aurora Cannabis (ACB) and Tilray (TLRY) quickly got into hemp and the stocks of companies that have long bet their business on CBD have doubled in recent months, including Charlotte’s Web (CWBHF) and GW Pharmaceuticals (GWPH), he notes. Unfortunately, there are no bargains among hemp or marijuana stocks these days, the author contends

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.